Akums Drugs and Pharmaceutical (AKUMS) — Cash Flow-to-Debt Ratio
Akums Drugs and Pharmaceutical (AKUMS) has a Cash Flow-to-Debt Ratio of 0.44x as of March 2025, meaning its operating cash flow of Rs4.65 Billion could theoretically repay 0% of its total liabilities (Rs10.50 Billion) in one year. Check Akums Drugs and Pharmaceutical (AKUMS) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Akums Drugs and Pharmaceutical Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for Akums Drugs and Pharmaceutical across 4 annual periods. Also explore balance sheet size of Akums Drugs and Pharmaceutical for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Akums Drugs and Pharmaceutical (2022–2025)
Year-by-year debt coverage analysis for Akums Drugs and Pharmaceutical. For market capitalisation and broader financial context, see market cap of Akums Drugs and Pharmaceutical.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.44x | Rs4.65 Billion | Rs10.50 Billion | ▲ +148.6% |
| 2024 | 0.18x | Rs4.98 Billion | Rs27.96 Billion | ▲ +156.6% |
| 2023 | 0.07x | Rs1.77 Billion | Rs25.43 Billion | ▲ +432.9% |
| 2022 | 0.01x | Rs318.54 Million | Rs24.44 Billion | — |